2017-2025 World RNAi for Therapeutic Market Research Report (by Product Type, End-User/Application and Regions/Countries)

December 2019 | 105 pages | ID: 2488C09C8C0EN
HeyReport

Abstracts

SUMMARY

RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression, typically by causing the destruction of specific mRNA molecules. Historically, it was known by other names, including co-suppression, post-transcriptional gene silencing (PTGS), and quelling. Only after these apparently unrelated processes were fully understood did it become clear that they all described the RNAi phenomenon. RNAi is now known as precise, efficient, stable and better than antisense technology for gene suppression.

This report includes market status and forecast of global and major regions, with introduction of vendors, regions, product types and end industries; and this report counts product types and end industries in global and major regions.

The report includes as follows:

The report provides current data, historical overview and future forecast.
The report includes an in-depth analysis of the Global market for RNAi for Therapeutic , covering Global total and major region markets.
The data of 2017-2025 are included. All-inclusive market are given through data on sales, consumption, and prices (Global total and by major regions).
The report provides introduction of leading Global manufacturers.
RNAi for Therapeutic market prospects to 2025 are included (in sales, consumption and price).

Market Segment as follows:

By Region / Countries

• North America (U.S., Canada, Mexico)
• Europe (Germany, U.K., France, Italy, Russia, Spain etc)
• Asia-Pacific (China, India, Japan, Southeast Asia etc)
• South America (Brazil, Argentina etc)
• Middle East & Africa (Saudi Arabia, South Africa etc)

By Type

• siRNA
• miRNA
• shRNA

By End-User / Application

• Cancer
• Cardiovascular
• HBV
• Others

By Company

• Alnylam Pharmaceuticals
• Arrowhead
• Dicerna Pharmaceuticals
• Mirna Therapeutics
• Quark Pharmaceuticals
• RXi Pharmaceuticals
• miRagen Therapeutics
• Gradalis
• Sirnaomics

Contents

1 MARKET DEFINITION

1.1 Market Segment Overview
1.2 by Type
1.3 by End-Use / Application

2 GLOBAL MARKET BY VENDORS

2.1 Market Share
2.2 Vendor Profile
2.3 Dynamic of Vendors

3 GLOBAL MARKET BY TYPE

3.1 Market Share
3.2 Introduction of End-Use by Different Products

4 GLOBAL MARKET BY END-USE / APPLICATION

4.1 Market Share
4.2 Overview of Consumption Characteristics
  4.2.1 Preference Driven
  4.2.2 Substitutability
  4.2.3 Influence by Strategy
  4.2.4 Professional Needs

5 GLOBAL MARKET BY REGIONS

5.1 Market Share
5.2 Regional Market Growth
  5.2.1 North America
  5.2.2 Europe
  5.2.3 Asia-Pacific
  5.2.4 South America
  5.2.5 Middle East & Africa

6 NORTH AMERICA MARKET

6.1 by Type
6.2 by End-Use / Application
6.3 by Regions

7 EUROPE MARKET

7.1 by Type
7.2 by End-Use / Application
7.3 by Regions

8 ASIA-PACIFIC MARKET

8.1 by Type
8.2 by End-Use / Application
8.3 by Regions

9 SOUTH AMERICA MARKET

9.1 by Type
9.2 by End-Use / Application
9.3 by Regions

10 MIDDLE EAST & AFRICA MARKET

10.1 by Type
10.2 by End-Use / Application
10.3 by Regions

11 MARKET FORECAST

11.1 Global Market Forecast (2020-2025)
11.2 Market Forecast by Regions (2020-2025)
11.3 Market Forecast by Type (2020-2025)
11.4 Market Forecast by End-Use / Application (2020-2025)

12 KEY MANUFACTURERS

12.TOSHIBA ALNYLAM PHARMACEUTICALS

  12.1.2 Company Overview
  12.1.2 Product and End-User / Application
  12.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
12.2 Arrowhead
12.3 Dicerna Pharmaceuticals
12.4 Mirna Therapeutics
12.5 Quark Pharmaceuticals
12.6 RXi Pharmaceuticals
12.7 miRagen Therapeutics
12.8 Gradalis
12.9 Sirnaomics

13 PRICE OVERVIEW

13.1 Price Segment
13.2 Price Trend

14 RESEARCH CONCLUSION

List Of Tables

LIST OF TABLES

Table Global RNAi for Therapeutic Market and Growth by Type
Table Global RNAi for Therapeutic Market and Growth by End-Use / Application
Table Global RNAi for Therapeutic Revenue (Million USD) by Vendors (2017-2019)
Table Global RNAi for Therapeutic Revenue Share by Vendors (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by Vendors (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by Vendors (2017-2019)
Table Headquarter, Factories & Sales Regions Comparison of Vendors
Table Product List of Vendors
Table Global RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Global RNAi for Therapeutic Market Share by Type (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by Type (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by Type (2017-2019)
Table Global RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by End-Use / Application (2017-2019)
Table Global RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Global RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Global RNAi for Therapeutic Market Volume (Volume) by Regions (2017-2019)
Table Global RNAi for Therapeutic Market Volume Share by Regions (2017-2019)
Table North America RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table North America RNAi for Therapeutic Market Share by Type (2017-2019)
Table North America RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table North America RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table North America RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table North America RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Europe RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Europe RNAi for Therapeutic Market Share by Type (2017-2019)
Table Europe RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Europe RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Europe RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Europe RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market Share by Type (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Asia-Pacific RNAi for Therapeutic Market Share by Regions (2017-2019)
Table South America RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table South America RNAi for Therapeutic Market Share by Type (2017-2019)
Table South America RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table South America RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table South America RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market (Million USD) by Type (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by Type (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market (Million USD) by End-Use / Application (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by End-Use / Application (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market (Million USD) by Regions (2017-2019)
Table Middle East & Africa RNAi for Therapeutic Market Share by Regions (2017-2019)
Table Global RNAi for Therapeutic Market (Million USD) Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market Share Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market Volume (Volume) Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market Volume Share Forecast by Regions (2020-2025)
Table Global RNAi for Therapeutic Market (Million USD) Forecast by Type (2020-2025)
Table Global RNAi for TherapeuticMarket Share by Forecast Type (2020-2025)
Table Global RNAi for Therapeutic Market (Million USD) Forecast by End-Use / Application (2020-2025)
Table Global RNAi for Therapeutic Market Share Forecast by End-Use / Application (2020-2025)
Table Sales Revenue, Volume, Price, Cost and Margin of Alnylam Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Arrowhead
Table Sales Revenue, Volume, Price, Cost and Margin of Dicerna Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of Mirna Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Quark Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of RXi Pharmaceuticals
Table Sales Revenue, Volume, Price, Cost and Margin of miRagen Therapeutics
Table Sales Revenue, Volume, Price, Cost and Margin of Gradalis
Table Sales Revenue, Volume, Price, Cost and Margin of Sirnaomics

List Of Figures

LIST OF FIGURES

Figure Global RNAi for Therapeutic Market Size (Million USD) 2017-2025
Figure North America Market Growth 2015-2018
Figure Europe Market Growth 2017-2019
Figure Asia-Pacific Market Growth 2017-2019
Figure South America Market Growth 2017-2019
Figure Middle East & Africa Market Growth 2017-2019
Figure Global RNAi for Therapeutic Market (Million USD) and Growth Forecast (2020-2025)
Figure Global RNAi for Therapeutic Market Volume (Volume) and Growth Forecast (2020-2025)